A detailed history of Altium Capital Management LP transactions in Rezolute, Inc. stock. As of the latest transaction made, Altium Capital Management LP holds 1,700,000 shares of RZLT stock, worth $7.48 Million. This represents 2.91% of its overall portfolio holdings.

Number of Shares
1,700,000
Previous 1,700,000 -0.0%
Holding current value
$7.48 Million
Previous $7.31 Million 12.78%
% of portfolio
2.91%
Previous 3.89%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$2.29 - $5.79 $3.89 Million - $9.84 Million
1,700,000 New
1,700,000 $7.31 Million
Q2 2022

Aug 15, 2022

BUY
$2.6 - $3.85 $1.07 Million - $1.58 Million
411,000 New
411,000 $1.33 Million
Q1 2022

May 16, 2022

SELL
$2.27 - $5.1 $522,100 - $1.17 Million
-230,000 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$7.45 - $13.66 $1.71 Million - $3.14 Million
230,000 New
230,000 $1.55 Million

Others Institutions Holding RZLT

About Rezolute, Inc.


  • Ticker RZLT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,827,600
  • Market Cap $171M
  • Description
  • Rezolute, Inc., a clinical stage biopharmaceutical company, develops transformative therapies for metabolic diseases associated with chronic glucose imbalance in the United States. The company's lead product candidate is RZ358, a human monoclonal antibody that is in Phase 2b clinical trial for the treatment of congenital hyperinsulinism, an ultr...
More about RZLT
Track This Portfolio

Track Altium Capital Management LP Portfolio

Follow Altium Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Altium Capital Management LP with notifications on news.